Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy

Area of Science:

• Oncology
• Immunology
• Cancer Research

Background:

• The traditional view of cold tumors as uniformly immune-insensitive is clinically misleading.
• Cold tumors represent a heterogeneous spectrum of resistance ecosystems.
• Current immunotherapy strategies may fail due to a lack of understanding of these diverse resistance mechanisms.

Purpose of the Study:

• To reframe the understanding of cold tumors from a singular state to a spectrum of resistance ecosystems.
• To identify key mechanistic drivers contributing to different cold tumor phenotypes.
• To propose a barrier-adaptive strategy for improving immunotherapy outcomes.

Main Methods:

• Dissecting tumor heterogeneity by linking mechanistic drivers to hot, immune-desert, and immune-excluded phenotypes.
• Analyzing drivers such as antigen processing defects, impaired T-cell priming, aberrant vasculature, stromal factors, metabolic exhaustion, and adaptive resistance.
• Evaluating conversion strategies based on their capacity to overcome specific rate-limiting barriers.

Main Results:

• Cold tumors exhibit heterogeneity driven by distinct, coexisting barriers.
• Defective antigen processing, impaired T-cell priming, physical exclusion, metabolic exhaustion, and adaptive resistance are key drivers.
• Emerging conversion strategies must target specific rate-limiting barriers for efficacy.

Conclusions:

• A universal "heating" strategy for cold tumors is unlikely to succeed.
• Durable clinical benefit depends on barrier-directed immune reprogramming tailored to specific resistance ecosystems.
• Iterative, biomarker-guided, and barrier-adaptive interventions are crucial for durable cold-to-hot tumor conversion and overcoming immunotherapy resistance.